During the past decade, Marin Cancer Institute at Marin General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marin Cancer Institute at Marin General Hospital" #1 sponsor was "SWOG Cancer Research Network" with 11 trials, followed by "Radiation Therapy Oncology Group" with 4 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marin Cancer Institute at Marin General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Marin Cancer Institute at Marin General Hospital" are "Breast Cancer" (5 trials), "Lung Cancer" (4 trials), "Prostate Cancer" (3 trials), "Leukemia" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Marin Cancer Institute at Marin General Hospital" in a lesser frequency.

Most popular intervention types in "Marin Cancer Institute at Marin General Hospital" are "Drug" (18 trials), "Radiation" (8 trials), "Biological" (6 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cetuximab" (4 trials), "cisplatin" (3 trials), "cyclophosphamide" (3 trials), "paclitaxel" (3 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Marin Cancer Institute at Marin General Hospital" are 15 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Marin Cancer Institute at Marin General Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Marin Cancer Institute at Marin General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marin Cancer Institute at Marin General Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".